Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis von Fernandes Felix, João Paulo, Cavalcanti Lira, Rodrigo Pessoa, Grupenmacher, Alex Treiger, Assis Filho, Hermano Lucio Gomes de, Cosimo, Alexandre Brito, Nascimento, Mauricio Abujamra, Leite Arieta, Carlos Eduardo

Volltext

Trimethoprim-Sulfamethoxazole versus Placebo in Reducing the Risk of Toxoplasmic Retinochoroiditis Recurrences: A three-year follow up von Felix, João Paulo Fernandes, MD, Lira, Rodrigo Pessoa Cavalcanti, MD, Cosimo, Alexandre Brito, MD, da Costa, Rodrigo Lourenço Cardeal, MD, Nascimento, Mauricio Abujamra, MD, Arieta, Carlos Eduardo Leite, MD

Volltext

Reply to Comment on: Long-term Results of Trimethoprim Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis von Fernandes Felix, João Paulo, Cavalcanti Lira, Rodrigo Pessoa, Grupenmacher, Alex Treiger, de Assis Filho, Hermano Lucio Gomes, Cosimo, Alexandre Brito, Nascimento, Mauricio Abujamra, Leite Arieta, Carlos Eduardo

Volltext